• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度多发性骨髓瘤的分布:发病率在年龄、性别和地理上的异质性。

Distribution of multiple myeloma in India: Heterogeneity in incidence across age, sex and geography.

机构信息

Haematology Division, ICMR - Regional Medical Research Centre, N.E. Region, 786010, Dibrugarh, Assam, India.

出版信息

Cancer Epidemiol. 2019 Apr;59:215-220. doi: 10.1016/j.canep.2019.02.010. Epub 2019 Mar 2.

DOI:10.1016/j.canep.2019.02.010
PMID:30831554
Abstract

BACKGROUND

This study aimed to investigate the distribution of multiple myeloma (MM) in India and provide a comprehensive narrative about its incidence, including differential patterns across age, sex and geography.

METHODS

MM cases diagnosed during 2012-14 were obtained from 27 populations based cancer registries in India by consulting the latest National Cancer Registry Programme reports. Crude (CR) and age-specific (ASR) rates of MM incidence were determined. Age-adjusted rates (AARs) were estimated by standardizing the CR values using age-specific weights recommended for LMIC countries (including India) for men and women separately, along with the corresponding 95% confidence interval (95% CI) measures.

RESULTS

Altogether, 1916 MM cases (male/female: 1123/793) were documented (i.e. 1.19% of all cancers, 95% CI: 1.14-1.24%). Overall CR of MM in India was 1.27 (95% CI: 1.20-1.35)/ 100,000 in men and 0.95 (95% CI: 0.89-1.02)/ 100,000 in women, while the corresponding AARs were 1.13 (95% CI: 1.07-1.20) and 0.81 (95% CI: 0.75 - 0.88) per 100,000 respectively. The ASR values increased steadily with age. Most cases belonged to the 60-69 yrs bracket. However, regional and sex-specific differences in MM profile were observed. MM incidence was highest in the Southern and Northern zones, and least in the Northeast. The Northern and Central zones had higher proportion of MM in the 50-59 yrs age group, whereas Eastern zone had higher proportion of cases aged 70 yrs and above.

CONCLUSION

Incidence of MM in India is presented. Marked variations in MM incidence were noted with respect to age, sex and geography.

摘要

背景

本研究旨在调查印度多发性骨髓瘤(MM)的分布情况,并提供其发病情况的全面叙述,包括年龄、性别和地理位置方面的差异模式。

方法

通过查阅最新的国家癌症登记计划报告,从印度的 27 个人口癌症登记处获取了 2012-14 年期间诊断的 MM 病例。确定了 MM 发病的粗发病率(CR)和年龄别发病率(ASR)。通过使用为印度等中等收入国家(LMIC)推荐的男女分别的年龄特异性权重对 CR 值进行标准化,估计了年龄调整发病率(AAR),并附有相应的 95%置信区间(95%CI)测量值。

结果

共记录了 1916 例 MM 病例(男/女:1123/793)(即所有癌症的 1.19%,95%CI:1.14-1.24%)。印度 MM 的总体 CR 为男性 1.27(95%CI:1.20-1.35)/100000,女性 0.95(95%CI:0.89-1.02)/100000,相应的 AAR 分别为 1.13(95%CI:1.07-1.20)和 0.81(95%CI:0.75-0.88)/100000。ASR 值随年龄稳步上升。大多数病例属于 60-69 岁年龄段。然而,观察到 MM 分布在区域和性别方面存在差异。南部和北部地区的 MM 发病率最高,东北地区最低。北部和中部地区 50-59 岁年龄组的 MM 比例较高,而东部地区 70 岁及以上年龄组的病例比例较高。

结论

报告了印度 MM 的发病率。在年龄、性别和地理位置方面,MM 的发病率存在明显差异。

相似文献

1
Distribution of multiple myeloma in India: Heterogeneity in incidence across age, sex and geography.印度多发性骨髓瘤的分布:发病率在年龄、性别和地理上的异质性。
Cancer Epidemiol. 2019 Apr;59:215-220. doi: 10.1016/j.canep.2019.02.010. Epub 2019 Mar 2.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦癌症负担及其变化:1990-2016 年全球疾病负担研究。
Lancet Oncol. 2018 Oct;19(10):1289-1306. doi: 10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12.
4
Temporal Trends and Future Prediction of Breast Cancer Incidence Across Age Groups in Trivandrum, South India.印度南部特里凡得琅各年龄组乳腺癌发病率的时间趋势及未来预测
Asian Pac J Cancer Prev. 2016;17(6):2895-9.
5
Monoclonal gammopathy in Iceland: a population-based registry and follow-up.冰岛的单克隆丙种球蛋白病:一项基于人群的登记和随访研究。
Br J Haematol. 2002 Jul;118(1):166-73. doi: 10.1046/j.1365-2141.2002.03589.x.
6
Leads to cancer control based on cancer patterns in a rural population in South India.基于印度南部农村人口癌症模式实现癌症控制。
Cancer Causes Control. 2000 May;11(5):433-9. doi: 10.1023/a:1008900425151.
7
Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis.2006 年至 2014 年印度甲状腺癌发病率及过度诊断的影响。
J Clin Endocrinol Metab. 2020 Aug 1;105(8):2507-14. doi: 10.1210/clinem/dgaa192.
8
Projection of cancer incident cases for India -till 2026.印度癌症发病病例预测——至2026年。
Asian Pac J Cancer Prev. 2013;14(7):4379-86.
9
Epidemiology of cancers among older adults in India: findings from the National Cancer Registry Programme.印度老年人癌症的流行病学:国家癌症登记计划的研究结果。
Public Health. 2023 Oct;223:230-239. doi: 10.1016/j.puhe.2023.08.002. Epub 2023 Sep 8.
10
Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.苏格兰东北部的多发性骨髓瘤:三十年发病率与生存率回顾
Health Bull (Edinb). 1996 May;54(3):232-40.

引用本文的文献

1
Prevalence, detection, and clinical implications of BRAF V600E and NRAS Q61R mutations in multiple myeloma BM-FFPE tissues using digital droplet PCR.使用数字液滴PCR检测多发性骨髓瘤骨髓福尔马林固定石蜡包埋组织中BRAF V600E和NRAS Q61R突变的患病率、检测情况及临床意义
Med Oncol. 2025 Sep 18;42(11):478. doi: 10.1007/s12032-025-03032-5.
2
Global, regional, and national burden of multiple myeloma, 1990 to 2021 and predictions to 2035: an analysis of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家多发性骨髓瘤负担及2035年预测:全球疾病负担研究2021分析
Front Med (Lausanne). 2025 Jul 31;12:1609692. doi: 10.3389/fmed.2025.1609692. eCollection 2025.
3
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma.
超越粒细胞集落刺激因子动员——从多发性骨髓瘤不同干细胞动员方案的15年经验中学习
Cancer Med. 2025 Jul;14(14):e71068. doi: 10.1002/cam4.71068.
4
Influence of PSMB6 and PSMB9 Genetic Polymorphisms on Bortezomib-Based Therapy Response in Newly Diagnosed Multiple Myeloma.PSMB6和PSMB9基因多态性对新诊断多发性骨髓瘤中基于硼替佐米治疗反应的影响
Cureus. 2025 Mar 24;17(3):e81081. doi: 10.7759/cureus.81081. eCollection 2025 Mar.
5
Association between radiotherapy and overall survival or cancer-specific survival in patients with solitary plasmacytoma of bone at pre-B cell grade: a real-world study using the SEER database.前B细胞分级的骨孤立性浆细胞瘤患者放疗与总生存期或癌症特异性生存期之间的关联:一项使用监测、流行病学和最终结果(SEER)数据库的真实世界研究
Ann Hematol. 2025 Apr;104(4):2461-2468. doi: 10.1007/s00277-025-06347-5. Epub 2025 Apr 14.
6
The Missing M Band: Is it Really Non Secretory Multiple Myeloma?缺失的M带:它真的是非分泌型多发性骨髓瘤吗?
EJIFCC. 2025 Feb 28;36(1):74-82. eCollection 2025 Mar.
7
The increasing prevalence of cancer in the elderly: An investigation of epidemiological trends.老年人癌症患病率的上升:流行病学趋势调查
Aging Med (Milton). 2024 Aug 18;7(4):516-527. doi: 10.1002/agm2.12347. eCollection 2024 Aug.
8
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India.新型药物方案治疗印度适合移植的新诊断多发性骨髓瘤患者的成本效益分析。
Appl Health Econ Health Policy. 2024 Jul;22(4):569-582. doi: 10.1007/s40258-024-00877-1. Epub 2024 Mar 7.
9
A population-based study on incidence trends of myeloma in the United States over 2000-2020.一项基于人群的研究,调查了 2000 年至 2020 年期间美国多发性骨髓瘤的发病趋势。
Sci Rep. 2023 Nov 24;13(1):20705. doi: 10.1038/s41598-023-47906-y.
10
Geospatial analysis of population-based incidence of multiple myeloma in the United States.基于人群的美国多发性骨髓瘤发病率的地理空间分析。
Cancer Epidemiol. 2023 Apr;83:102343. doi: 10.1016/j.canep.2023.102343. Epub 2023 Feb 24.